RL
Highly rated in
29
conditions
Highly rated in
29
conditions
Check Dr. Robert A. Lustig's experience treating your condition:
About Dr. Robert A. Lustig

Robert Lustig is a Radiation Oncologist and a Radiologist in Philadelphia, Pennsylvania. Lustig has been practicing medicine for over 46 years and is highly rated in 29 conditions, according to our data. His top areas of expertise are Glioblastoma, Astrocytoma, Brain Tumor, and Glioma. He is licensed to treat patients in Pennsylvania. Lustig is currently accepting new patients.

His clinical research consists of co-authoring 62 peer reviewed articles and participating in 6 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Robert A. Lustig it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Robert A. Lustig accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
Locations
3400 Civic Center Blvd, Philadelphia, PA 19104
Background & Education
Graduate Institution
Jefferson Medical College Of Thomas Jefferson University, 1976
Specialties
Radiation Oncology
Radiology
Licenses
Therapeutic Radiology in PA
Hospital Affiliations
Hospital Of The University Of Pennsylvania
Childrens Hospital Of Philadelphia
Penn Presbyterian Medical Center
Pennsylvania Hospital
Chestnut Hill Hospital
Doylestown Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

Detection of Vascular and Neuronal Changes Following Proton and/or Photon Radiotherapy in Patients Receiving Skull Base and/or Brain Radiation
Phase II Study of R115777 for the Treatment of Adults With Newly Diagnosed Glioblastoma Multiforme
Proton Radiation for Low Grade Gliomas
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Circulating Tumor Markers for High Grade Glioma
View 5 Less Clinical Trials -

62 Total Publications

Life-threatening altered mental status secondary to memantine in an adolescent undergoing cranial radiotherapy for medulloblastoma.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors